black haw |
American Sloe; stag bush; sweet viburnum |
Clinical Trial: Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
This study has been completed.
Purpose
To seek predictors of mortality, hospitalization, and dialysis using data from a hypertensive population which began treatment in 1974.
| Condition |
|---|
| Cardiovascular Diseases Heart Diseases Hypertension Kidney Failure, Chronic |
MedlinePlus related topics: Heart Diseases; Heart Diseases--Prevention; High Blood Pressure; Kidney Failure; Vascular Diseases
Study Type: Observational
Study Design: Natural History
Study start: September 1991; Study completion: September 1993
DESIGN NARRATIVE: Patients dying before 1989 were identified using the VA's Beneficiary Identification Records Location Subsystem and the National Death Index (NDI). Using NDI information to locate them, death certificates were obtained on all dead patients. Arrangements were made to collect data on the VA hospitalizations occurring after antihypertensive treatment had begun, and application was made to match patients against the USRDS Dialysis and Transplant Registry. The basic clinical data were collected in 32 VA Hypertension Screening and Treatment Program (HSTP) clinics during the 40 month period beginning in 1974. Approximately 30,000 completed Screening and Evaluation Forms and 75,000 Treatment Visit Forms were completed during the 40 months of data collection. The collected information was entered into the HSTP Master File at the VA Computer Center in Austin, Texas. Predictors were sought for (1) all-cause mortality, (2) cause-specific mortality (obtained from death certificates and hospitalization and clinic records), (3) endstage renal disease (obtained from the USRDS Dialysis and Transplant Registry), (4) VA hospital usage combined with other data related to cost care.
Eligibility
Genders Eligible for Study: Male
Criteria
More Information
Publications
Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995 Apr;25(4 Pt 1):587-94.
Record last reviewed: May 2000
Last Updated: October 13, 2004
Record first received: May 25, 2000
ClinicalTrials.gov Identifier: NCT00005417
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -

